Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.

Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Abstract Text:

    maki sugimotoMaki Sugimoto,hideki yasudaHideki Yasuda,keiji kodaKeiji Koda,masato yamazakiMasato Yamazaki,tohru tezukaTohru Tezuka,tomohiro takenoueTomohiro Takenoue,chihiro kosugiChihiro Kosugi,ryota higuchiRyota Higuchi,shiho yamamotoShiho Yamamoto,yoshihisa watayoYoshihisa Watayo,yohsuke yagawaYohsuke Yagawa,masato suzukiMasato Suzuki,maki sugimotoMaki Sugimoto,hideki yasudaHideki Yasuda,keiji kodaKeiji Koda,masato yamazakiMasato Yamazaki,tohru tezukaTohru Tezuka,tomohiro takenoueTomohiro Takenoue,chihiro kosugiChihiro Kosugi,ryota higuchiRyota Higuchi,shiho yamamotoShiho Yamamoto,yoshihisa watayoYoshihisa Watayo,yohsuke yagawaYohsuke Yagawa,masato suzukiMasato Suzuki,

    Liver metastasis is an important prognostic factor in colorectal cancer. The efficacy of resection of metastatic lesions in liver metastasis of colorectal cancer is also widely recognized. However, studies on treatment methods of unresectable cases have not been sufficient and obtaining complete remission (CR) for liver metastasis is rare with chemotherapy. Selection of reliable chemotherapy for unresectable liver metastasis is an urgent necessity. The usefulness of oxaliplatin, 5-flurouracil and leucovorin combination therapy (FOLFOX) has recently been reported, but CR of liver metastasis is rare. The current status and new therapeutic significance of FOLFOX therapy are discussed based on the literature of colorectal cancer chemotherapy to date, and the clinical experience in which we obtained CR for liver metastasis is reported. The patient had stage IV rectal cancer, perforative peritonitis, pelvic abscess and simultaneous multiple liver metastasis. The patient underwent an emergency operation using the Hartmann's procedure. Liver metastasis is considered to be a prognostic factor and FOLFOX was selected as the postoperative chemotherapy, CR of the liver metastasis was obtained. FOLFOX was suggested to have new clinical significance in oncologic emergencies against unresectable liver metastasis in colorectal cancer and should serve as adjuvant chemotherapy that will contribute to improvement of treatment results.

    Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Publishing Authors By Initials

    m sugimotoM Sugimoto,h yasudaH Yasuda,k kodaK Koda,m yamazakiM Yamazaki,t tezukaT Tezuka,t takenoueT Takenoue,c kosugiC Kosugi,r higuchiR Higuchi,s yamamotoS Yamamoto,y watayoY Watayo,y yagawaY Yagawa,m suzukiM Suzuki,m sugimotoM Sugimoto,h yasudaH Yasuda,k kodaK Koda,m yamazakiM Yamazaki,t tezukaT Tezuka,t takenoueT Takenoue,c kosugiC Kosugi,r higuchiR Higuchi,s yamamotoS Yamamoto,y watayoY Watayo,y yagawaY Yagawa,m suzukiM Suzuki,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Hepato-gastroenterology

    VOLUME: 54

    Page Numbers: 1684-8

    Journal Abbreviation: Hepatogastroenterology

    ISSN: 0172-6390

    DAY: 16

    MONTH: Sep

    YEAR: 2007

    Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8007849

    Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.

    AFFILIATION: Department of Surgery, Teikyo University Chiba Medical Center, Chiba, Japan. sugimoto@med.teikyo-u.ac.jp

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hepatogastroenterology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News